A Novel Nonpeptide CGRP Receptor Antagonist, ‘Compound 1’ (WO98/11128) Is a High Affinity Competitive Antagonist at the CGRP1 Receptor in Human Coronary Arteries

A Novel Nonpeptide CGRP Receptor Antagonist, ‘Compound 1’ (WO98/11128) Is a High Affinity Competitive Antagonist at the CGRP1 Receptor in Human Coronary Arteries

Saved in:

Bibliographic Details
Main Authors:	P. Hasbak, O. Saetrum Opgaard, K. Eskesen, S. Schifter, H. Arendrup, J. Longmore, L. Edvinsson
Format:	Article
Language:	English
Published:	Wiley 2001-01-01
Series:	The Scientific World Journal
Online Access:	http://dx.doi.org/10.1100/tsw.2001.416
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New CGRP Antagonists
by: H. N. Doods, et al.
Published: (2001-01-01)

Variant angina associated with a CGRP receptor antagonist: a case report
by: Hongki Jeon, et al.
Published: (2025-05-01)

RAMP1-dependent hormonal regulation of CGRP and its receptor in the trigeminal ganglion
by: Anja Holm, et al.
Published: (2025-06-01)

Relative mRNA Quantification of Calcitonin Receptor-Like Receptor (CRLR) and Receptor Activity Modifying Proteins (RAMPs) by Real-Time PCR
by: K. Eskesen, et al.
Published: (2001-01-01)

Pipeline for development of acylated peptide based CGRP receptor antagonist with extended half-life for migraine treatment
by: Jens Bjelke Kristensen, et al.
Published: (2025-01-01)

Peripheral Nerve Injury and CGRP Receptor Antagonist Modulate RCP-1 Expression in Primary Sensory Neurons and in Neurons of the Spinal Cord
by: W. Ma, et al.
Published: (2001-01-01)

Sex differences in expression of CGRP family of receptors and ligands in the rat trigeminal system
by: Aida Maddahi, et al.
Published: (2024-11-01)

CGRP in Primary Headaches
by: Lars Edvinsson
Published: (2001-01-01)

The Role of Cgrp-Receptor Component Protein (Rcp) in Cgrp-Mediated Signal Transduction
by: M. A. Prado, et al.
Published: (2001-01-01)

Multiple Receptor Subtypes for the CGRP Super-Family
by: R. Quirion, et al.
Published: (2001-01-01)

Functional Characterisation of the CGRP Antagonist BIBN4096BS, in SK-N-MC Cells
by: Marcus Schindler, et al.
Published: (2001-01-01)

Pharmacological Differences between Human and Rat CGRP Receptors Are Determined by RAMP1
by: S. Kane, et al.
Published: (2001-01-01)

Small-molecule CGRP antagonist atogepant does not affect cortical spreading depression susceptibility in rats
by: Xuyan Jin, et al.
Published: (2025-08-01)

Magnetic mesoporous silica loaded with CGRP antagonist and curcumin coated with cerium oxide for the treatment of neuropathic pain
by: Yue Tian, et al.
Published: (2025-06-01)

CGRP Receptor Family and Accessory Protein Localization: Implications for Predicted Function
by: K.R. Oliver
Published: (2001-01-01)

Cgrp Characterization And Classification
by: Ian Marshall
Published: (2001-01-01)

Croatian guidelines for specific preventive treatment of migraine with monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) (eptinezumab, fremanezumab, and galcanezumab) or the CGRP receptor (erenumab)
by: Davor Jančuljak, et al.
Published: (2024-01-01)

Enhanced Vasodilator Responses to CGRP (Calcitonin Gene-Related Peptide) in Subcutaneous Arteries in Human Hypertension
by: H. Lind, et al.
Published: (2001-01-01)

Differentially localizing isoforms of the migraine component calcitonin gene-related peptide (CGRP), in the mouse trigeminal ganglion: βCGRP is translated but, unlike αCGRP, not sorted into axons
by: Sofia Lyng Wæver, et al.
Published: (2025-01-01)

Structural Determinants in the Calcitonin Receptor-Like Receptor (Crlr) Important for Cgrp and Adrenomedullin (Am) Receptor Function of Crlr/Receptor-Activity-Modifying Protein (Ramp) 1 and Crlr/Ramp2 Heterodimers
by: W. Born, et al.
Published: (2001-01-01)

The interleukin-1 receptor antagonist influences interleukin-1 effects in rat and mouse
by: P. Bjrök, et al.
Published: (1992-01-01)

Introduction of Leukotriene Receptor Antagonists in Manitoba
by: C Macie, et al.
Published: (2006-01-01)

Leukotriene Receptor Antagonists and Related Compounds
by: Sally E Wenzel
Published: (1999-01-01)

Difficult choice: angiotensin receptor antagonists
by: E. O. Taratukhin
Published: (2013-04-01)

Role of Leukotriene Receptor Antagonists in Asthma
by: Chih-Hsing Hung
Published: (2012-08-01)

ANGIOTENSIN RECEPTOR ANTAGONISTS: GOING WITH THE TIMES
by: E. O. Taratukhin
Published: (2013-06-01)

Angiotensin II type 1 receptor antagonists and their combinations in the treatment of hypertension
by: J.A. Ker
Published: (2012-06-01)

Mitoprotective effect of the receptor antagonist interleukin-1 in experimental cerebral stroke
by: E. V. Suprun
Published: (2012-12-01)

Synthesis and Pharmacological Characterization of a Novel Cannabinoid Receptor 1 Antagonist
by: Iker Bengoetxea de Tena, et al.
Published: (2025-06-01)

The effect of CGRP monoclonal antibodies on cardiovascular disease
by: Adam Sinker, et al.
Published: (2025-07-01)

Signalling by CGRP and Adrenomedullin in the Cerebellum and Other Systems
by: David Poyner, et al.
Published: (2001-01-01)

Revisiting the role of Substance P and CGRPα
by: Weihua Cai, et al.
Published: (2025-04-01)

MetaCGRP is a high-precision meta-model for large-scale identification of CGRP inhibitors using multi-view information
by: Nalini Schaduangrat, et al.
Published: (2024-10-01)

Metabolic syndrome and angiotensin II receptor antagonists
by: K. M. Mamyrbayeva, et al.
Published: (2007-04-01)

The role of endothelin receptor antagonists in kidney disease
by: Xiaoting Ma, et al.
Published: (2025-12-01)

NMDA receptor antagonists in the treatment of neurological diseases
by: I. S. Preobrazhenskaya
Published: (2020-10-01)

The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release
by: G. S. Smith, et al.
Published: (1996-01-01)

Cryo-EM structures of ρ1 GABAA receptors with antagonist and agonist drugs
by: Chen Fan, et al.
Published: (2025-08-01)

Angiotensin receptor-1 antagonist eprosartan in patients with mild to moderate arterial hypertension
by: A. V. Shabalin, et al.
Published: (2005-12-01)

Influence of Constipation in the Behavior of Circulating Alpha- and Beta-CGRP Levels in Chronic/High-Frequency Migraine Patients After CGRP Monoclonal Antibodies
by: Gabriel Gárate, et al.
Published: (2025-05-01)